| mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
1e-09 |
| mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-08 |
| mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-07 |
| mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-06 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-06 |
| mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-06 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
8e-06 |
| mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-06 |